These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19460456)

  • 1. Novel antibody-based strategies for the rapid diagnosis of mitochondrial disease and dysfunction.
    Marusich MF; Murray J; Xie J; Capaldi RA
    Int J Biochem Cell Biol; 2009 Oct; 41(10):2081-8. PubMed ID: 19460456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels.
    Steinkellner H; Scheiber-Mojdehkar B; Goldenberg H; Sturm B
    Anal Chim Acta; 2010 Feb; 659(1-2):129-32. PubMed ID: 20103114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron dysregulation in Friedreich ataxia.
    Wilson RB
    Semin Pediatr Neurol; 2006 Sep; 13(3):166-75. PubMed ID: 17101455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemical form of mitochondrial iron in Friedreich's ataxia.
    Popescu BF; Pickering IJ; George GN; Nichol H
    J Inorg Biochem; 2007 Jun; 101(6):957-66. PubMed ID: 17475338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo mitochondrial two-step maturation of human frataxin.
    Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H
    Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic testing in mitochondrial disease.
    Dougherty FE
    Semin Neurol; 2001 Sep; 21(3):303-8. PubMed ID: 11641820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
    Cooper JM; Schapira AH
    Mitochondrion; 2007 Jun; 7 Suppl():S127-35. PubMed ID: 17485244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frataxin deficiency causes upregulation of mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe-S proteins.
    Guillon B; Bulteau AL; Wattenhofer-Donzé M; Schmucker S; Friguet B; Puccio H; Drapier JC; Bouton C
    FEBS J; 2009 Feb; 276(4):1036-47. PubMed ID: 19154341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays.
    Willis JH; Capaldi RA; Huigsloot M; Rodenburg RJ; Smeitink J; Marusich MF
    Biochim Biophys Acta; 2009 May; 1787(5):533-8. PubMed ID: 19041632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoresis techniques to investigate defects in oxidative phosphorylation.
    Calvaruso MA; Smeitink J; Nijtmans L
    Methods; 2008 Dec; 46(4):281-7. PubMed ID: 18948205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional mouse models for Friedreich ataxia, a neurodegenerative disorder associating cardiomyopathy.
    Puccio H
    Handb Exp Pharmacol; 2007; (178):365-75. PubMed ID: 17203663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of the yeast frataxin homolog (Yfh1): contrasting effects on iron-sulfur cluster assembly, heme synthesis and resistance to oxidative stress.
    Seguin A; Bayot A; Dancis A; Rogowska-Wrzesinska A; Auchère F; Camadro JM; Bulteau AL; Lesuisse E
    Mitochondrion; 2009 Apr; 9(2):130-8. PubMed ID: 19460301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-induced mitochondrial damage and disease.
    Neustadt J; Pieczenik SR
    Mol Nutr Food Res; 2008 Jul; 52(7):780-8. PubMed ID: 18626887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial fatty-acid oxidation disorders.
    Kompare M; Rizzo WB
    Semin Pediatr Neurol; 2008 Sep; 15(3):140-9. PubMed ID: 18708005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-based approaches toward Friedreich ataxia therapeutics.
    Hebert MD; Whittom AA
    Cell Mol Life Sci; 2007 Dec; 64(23):3034-43. PubMed ID: 17828464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial disease: a practical approach for primary care physicians.
    Haas RH; Parikh S; Falk MJ; Saneto RP; Wolf NI; Darin N; Cohen BH
    Pediatrics; 2007 Dec; 120(6):1326-33. PubMed ID: 18055683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assaying ATP synthesis in cultured cells: a valuable tool for the diagnosis of patients with mitochondrial disorders.
    Rizza T; Vazquez-Memije ME; Meschini MC; Bianchi M; Tozzi G; Nesti C; Piemonte F; Bertini E; Santorelli FM; Carrozzo R
    Biochem Biophys Res Commun; 2009 May; 383(1):58-62. PubMed ID: 19332025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The conserved Trp155 in human frataxin as a hotspot for oxidative stress related chemical modifications.
    Correia AR; Ow SY; Wright PC; Gomes CM
    Biochem Biophys Res Commun; 2009 Dec; 390(3):1007-11. PubMed ID: 19853582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics and mitochondrial dysfunction: a future perspective.
    Siciliano G; Pasquali L; Mancuso M; Murri L
    Expert Rev Mol Diagn; 2008 Jul; 8(4):531-49. PubMed ID: 18598232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.